Sainte-Geneviève-des-Bois, France

Denis Martin

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi-Synthelabo. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denis Martin. Retrieved from https://idiyas.com/inventor/denis-martin-xw5trj1y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Denis Martin - Innovator in Medical Chemistry

Introduction

Denis Martin is a notable inventor based in Sainte-Geneviève-des-Bois, France. He has made significant contributions to the field of medical chemistry, particularly in the development of treatments for male reproductive health issues. His innovative work has led to the filing of a patent that addresses a critical medical condition.

Latest Patents

Denis Martin holds a patent for the "Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia." This patent highlights the use of a compound with the formula (I), which has the potential to improve the quality of life for individuals suffering from these conditions. He has 1 patent to his name, showcasing his dedication to advancing medical science.

Career Highlights

Denis Martin is associated with Sanofi-Synthelabo, a leading global healthcare company. His role at the company has allowed him to collaborate with other talented professionals in the field. His work is characterized by a commitment to innovation and a focus on developing effective medical solutions.

Collaborations

Throughout his career, Denis has worked alongside esteemed colleagues such as Sonia Arbilla and Itzchak Angel. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking medical treatments.

Conclusion

Denis Martin's contributions to medical chemistry exemplify the impact of innovation in healthcare. His patent for treating retrograde ejaculation and aspermia demonstrates his commitment to improving patient outcomes. Through his work at Sanofi-Synthelabo and collaborations with other professionals, he continues to make strides in the field of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…